Psychiatric polygenic risk scores: Child and adolescent psychiatrists' knowledge, attitudes, and experiences

被引:7
作者
Pereira, Stacey [1 ]
Munoz, Katrina A. [2 ]
Small, Brent J. [3 ]
Soda, Takahiro [4 ]
Torgerson, Laura N. [1 ]
Sanchez, Clarissa E. [5 ]
Austin, Jehannine [6 ]
Storch, Eric A. [7 ]
Lazaro-Munoz, Gabriel [8 ]
机构
[1] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA
[2] Emory Univ, Sch Med, Atlanta, GA USA
[3] Univ S Florida, Sch Aging Studies, Tampa, FL 33620 USA
[4] Univ Florida, Dept Psychiat, Coll Med, Gainesville, FL 32611 USA
[5] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA
[6] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada
[7] Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA
[8] Harvard Med Sch, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
genetics; pediatrics; pharmacotherapy; polygenic risk scores; psychiatric practice; NEUROBIOLOGY; DISORDERS;
D O I
10.1002/ajmg.b.32912
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Psychiatric polygenic risk scores (PRS) have potential utility in psychiatric care and prevention, but there are concerns about their implementation. We surveyed 960 US-based practicing child and adolescent psychiatrists' (CAP) about their experiences, perspectives, and potential uses of psychiatric PRS. While 23% of CAP reported that they had never heard of PRS, 10 % of respondents have had a patient/family bring PRS to them and 4% have generated PRS for patients. Though 25% stated they would request PRS if a patient/caregiver asked, 35% indicated that nothing would prompt them to request PRS. Most respondents (54%) believed psychiatric PRS are currently at least slightly useful and 87% believed they will be so in 5 years. More than 70% indicated they would take action in response to a child with a top fifth percentile psychiatric PRS but no diagnosis: 48% would increase monitoring of symptoms, 42% would evaluate for current symptoms, and 4% would prescribe medications. Yet, most respondents were concerned that high-PRS results could lead to overtreatment and negatively impact patients' emotional well-being. Findings indicate emerging use of psychiatric PRS within child and adolescent psychiatry in the US. It is critical to examine the ethical and clinical challenges that PRS may generate and begin efforts to promote their informed and responsible use.
引用
收藏
页码:293 / 302
页数:10
相关论文
共 40 条
  • [1] Risk of Early-Onset Depression Associated With Polygenic Liability, Parental Psychiatric History, and Socioeconomic Status
    Agerbo, Esben
    Trabjerg, Betina B.
    Borglum, Anders D.
    Schork, Andrew J.
    Vilhjalmsson, Bjarni J.
    Pedersen, Carsten B.
    Hakulinen, Christian
    Albinana, Clara
    Hougaard, David M.
    Grove, Jakob
    McGrath, John J.
    Bybjerg-Grauholm, Jonas
    Mors, Ole
    Plana-Ripoll, Oleguer
    Werge, Thomas
    Wray, Naomi R.
    Mortensen, Preben Bo
    Musliner, Katherine L.
    [J]. JAMA PSYCHIATRY, 2021, 78 (04) : 387 - 397
  • [2] Parents' experiences of receiving their child's genetic diagnosis: A qualitative study to inform clinical genetics practice
    Ashtiani, Setareh
    Makela, Nancy
    Carrion, Prescilla
    Austin, Jehannine
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2014, 164 (06) : 1496 - 1502
  • [3] Genetic Counseling for Common Psychiatric Disorders: An Opportunity for Interdisciplinary Collaboration
    Austin, Jehannine
    Inglis, Angela
    Hadjipavlou, George
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2014, 171 (05) : 584 - 585
  • [4] Evidence-Based Genetic Counseling for Psychiatric Disorders: A Road Map
    Austin, Jehannine C.
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2020, 10 (06):
  • [5] CDC, MENT HLTH SURV CHILD
  • [6] Prodromal interventions for schizophrenia vulnerability: the risks of being "at risk"
    Corcoran, C
    Malaspina, D
    Hercher, L
    [J]. SCHIZOPHRENIA RESEARCH, 2005, 73 (2-3) : 173 - 184
  • [7] Clinical relevance of genome-wide polygenic score may be less than claimed
    Curtis, David
    [J]. ANNALS OF HUMAN GENETICS, 2019, 83 (04) : 274 - 277
  • [8] Meta-analysis of the Interval between the Onset and Management of Bipolar Disorder
    Dagani, Jessica
    Signorini, Giulia
    Nielssen, Olav
    Bani, Moira
    Pastore, Adriana
    de Girolamo, Giovanni
    Large, Matthew
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2017, 62 (04): : 247 - 258
  • [9] The effects of learning about one's own genetic susceptibility to alcoholism: a randomized experiment
    Dar-Nimrod, Ilan
    Zuckerman, Miron
    Duberstein, Paul R.
    [J]. GENETICS IN MEDICINE, 2013, 15 (02) : 132 - 138
  • [10] Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder
    Demontis, Ditte
    Walters, Raymond K.
    Martin, Joanna
    Mattheisen, Manuel
    Als, Thomas D.
    Agerbo, Esben
    Baldursson, Gisli
    Belliveau, Rich
    Bybjerg-Grauholm, Jonas
    Baekvad-Hansen, Marie
    Cerrato, Felecia
    Chambert, Kimberly
    Churchhouse, Claire
    Dumont, Ashley
    Eriksson, Nicholas
    Gandal, Michael
    Goldstein, Jacqueline I.
    Grasby, Katrina L.
    Grove, Jakob
    Gudmundsson, Olafur O.
    Hansen, Christine S.
    Hauberg, Mads Engel
    Hollegaard, Mads V.
    Howrigan, Daniel P.
    Huang, Hailiang
    Maller, Julian B.
    Martin, Alicia R.
    Martin, Nicholas G.
    Moran, Jennifer
    Pallesen, Jonatan
    Palmer, Duncan S.
    Pedersen, Carsten Bocker
    Pedersen, Marianne Giortz
    Poterba, Timothy
    Poulsen, Jesper Buchhave
    Ripke, Stephan
    Robinson, Elise B.
    Satterstrom, F. Kyle
    Stefansson, Hreinn
    Stevens, Christine
    Turley, Patrick
    Walters, G. Bragi
    Won, Hyejung
    Wright, Margaret J.
    Andreassen, Ole A.
    Asherson, Philip
    Burton, Christie L.
    Boomsma, Dorret I.
    Cormand, Bru
    Dalsgaard, Soren
    [J]. NATURE GENETICS, 2019, 51 (01) : 63 - +